RGT 2.00% 25.5¢ argent biopharma limited

Ann: INVESTOR PRESENTATION, page-8

  1. 13,856 Posts.
    lightbulb Created with Sketch. 2357
    There has to be a CR at some stage - and sooner than later. MXC is a bit cash strapped at the moment.

    If they intend to use the Malta facility then they will need funds to ramp up production - and then hope they can flog off what they produce.

    With the POMs clearly interested in MXC then they may as well strike while the iron is hot - in a few months time, that opportunity may not be there. They can't survive making a $4 -5mil loss every year. They need to expand sales significantly.

    Getting some cash now - and they should aim for $10mil - and then a consolidation in 6 months time would be a prudent strategy - to be honest, they don't really have an alternative one available to them. They can't borrow any more - no one will give them funds.

    The last time around, they had to rely on "death spiral financing" to get any funds - they sold their soul even though they probably had a shortfall in that area.

    One way or the other, the next 12 months will be a tumultuous time for MXC. Maybe they are considering putting MXC on the open market in that time. I certainly have my doubts they will be around a year from now as an independent entity.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.